These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7305078)

  • 1. Acute effects of albuterol aerosol in reversible obstructive airway disease.
    Falliers CJ
    Ann Allergy; 1981 Nov; 47(5 Pt 2):387-91. PubMed ID: 7305078
    [No Abstract]   [Full Text] [Related]  

  • 2. The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
    Middleton E
    Ann Allergy; 1981 Nov; 47(5 Pt 2):427-8. PubMed ID: 6795977
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary function and airways resistance studies on chronic stabilized asthma: comparison of acute and long-term effects of albuterol and isoproterenol aerosols.
    Tomashefski JF
    Ann Allergy; 1981 Nov; 47(5 Pt 2):415-20. PubMed ID: 7305082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and physiopathological study of obstructive bronchopneumopathies treated with salbutamol].
    Giuliano V; Martelli GC; Verrua D
    Minerva Med; 1976 Mar; 67(16):1067-9. PubMed ID: 1264382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Respiratory function studies in patients with bronchopneumopathy treated with salbutamol].
    Spina G; Bonsignore C
    Minerva Med; 1976 Mar; 67(15):995-7. PubMed ID: 1264372
    [No Abstract]   [Full Text] [Related]  

  • 6. Bronchodilatation by metered inhaler (Prenomiser) in obstructive airway disease.
    Store SD; Kamat SR; Purohit SD; Rane MA
    J Assoc Physicians India; 1974 Jul; 22(7):515-9. PubMed ID: 4436242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
    Kersten W
    Fortschr Med; 1974 Apr; 92(11):487-91. PubMed ID: 4822455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
    Melillo G; D'Amato G; Cocco G
    Minerva Med; 1976 Mar; 67(15):964-8. PubMed ID: 1264368
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between R t and FEV 1.0 before and after inhalation of isoproterenol in patients with chronic obstructive syndrome.
    Stadeler HJ; Ferlinz R; Del Valle-Monge J
    Bull Physiopathol Respir (Nancy); 1971; 7(3):555-9. PubMed ID: 5119275
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of albuterol aerosol in the relief of bronchospasm.
    Bedell GN; Richardson RA
    Ann Allergy; 1981 Nov; 47(5 Pt 2):392-3. PubMed ID: 7305079
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects of albuterol aerosol in the treatment of asthma.
    George RB; Jenkinson SG; Light RW
    Ann Allergy; 1981 Nov; 47(5 Pt 2):384-6. PubMed ID: 7030153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
    Babolini G; Gemelli M; Capone M; Coglitore G; Ministeri S; Girbino G; Pinizzotto G; Barberio G
    Minerva Med; 1976 Mar; 67(16):1058-66. PubMed ID: 1264381
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac and pulmonary effects of therapy with albuterol and isoproterenol.
    Whitsett TL; Manion CV
    Chest; 1978 Sep; 74(3):251-5. PubMed ID: 357097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the bronchodilator effects of aerosol carbuterol and isoproterenol in chronic obstructive lung disease.
    Kulpati DD; Bogra KC; Kinra V; Kamath R
    J Assoc Physicians India; 1981 Dec; 29(12):990-7. PubMed ID: 6897242
    [No Abstract]   [Full Text] [Related]  

  • 15. Symposium on reversible chronic obstructive airway disease and the clinical application of albuterol. January 28, 1981, Washington, D.C.
    Ann Allergy; 1981 Nov; 47(5 Pt 2):375-428. PubMed ID: 6118081
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of selective agonist beta-adrenergic receptors on lung ventilation function in patients with chronic obstructive pulmonary disease].
    Szczegielniak J
    Pol Merkur Lekarski; 1998 Feb; 4(20):72-4. PubMed ID: 9591437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing of lung function after theophylline inhalation (author's transl)].
    Greger G
    Z Erkr Atmungsorgane; 1981; 157(3):270-5. PubMed ID: 7340211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical results of the phenylephrine, isoprenaline, and atropine association in the treatment of obstructive respiratory insufficiency].
    Pino G; Rovera R; Cozza G
    Minerva Med; 1972 Jan; 63(5):308-19. PubMed ID: 4551951
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.